-
1
-
-
84864493727
-
ESC Committee for Practice Guidelines. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
-
McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K, et al; ESC Committee for Practice Guidelines. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2012;33(14):1787-847.
-
(2012)
Eur Heart J
, vol.33
, Issue.14
, pp. 1787-1847
-
-
McMurray, J.J.1
Adamopoulos, S.2
Anker, S.D.3
Auricchio, A.4
Böhm, M.5
Dickstein, K.6
-
2
-
-
60449094498
-
Heart disease and stroke statistics-2009 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
-
Lloyd-Jones D, Adams R, Carnethon M, De Simone G, Ferguson TB, Flegal K, et al. Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2009;119(3):480-6.
-
(2009)
Circulation
, vol.119
, Issue.3
, pp. 480-486
-
-
Lloyd-Jones, D.1
Adams, R.2
Carnethon, M.3
De Simone, G.4
Ferguson, T.B.5
Flegal, K.6
-
3
-
-
0042357093
-
Electrophysiological effects of a single intravenous administration of ivabradine (S 16257) in adult patients with normal baseline electrophysiology
-
Camm AJ, Lau CP. Electrophysiological effects of a single intravenous administration of ivabradine (S 16257) in adult patients with normal baseline electrophysiology. Drugs. 2003;4(2):83-9.
-
(2003)
Drugs
, vol.4
, Issue.2
, pp. 83-89
-
-
Camm, A.J.1
Lau, C.P.2
-
4
-
-
0344394916
-
A single intravenous dose of ivabradine, a novel I(f) inhibitor, lowers heart rate but does not depress left ventricular function in patients with left ventricular dysfunction
-
Manz M, Reuter M, Lauck G, Omran H, Jung W. A single intravenous dose of ivabradine, a novel I(f) inhibitor, lowers heart rate but does not depress left ventricular function in patients with left ventricular dysfunction. Cardiology. 2003;100(3):149-55.
-
(2003)
Cardiology
, vol.100
, Issue.3
, pp. 149-155
-
-
Manz, M.1
Reuter, M.2
Lauck, G.3
Omran, H.4
Jung, W.5
-
5
-
-
84859210318
-
Effect of ivabradine vs atenolol on heart rate and effort tolerance in patients with mild to moderate mitral stenosis and normal sinus rhythm
-
Parakh N, Chaturvedi V, Kurian S, Tyagi S. Effect of ivabradine vs atenolol on heart rate and effort tolerance in patients with mild to moderate mitral stenosis and normal sinus rhythm. J Card Fail. 2012;18(4):282-8.
-
(2012)
J Card Fail
, vol.18
, Issue.4
, pp. 282-288
-
-
Parakh, N.1
Chaturvedi, V.2
Kurian, S.3
Tyagi, S.4
-
6
-
-
77956612624
-
Ivabradine and outcomes in chronic heart failure (SHIFT): A randomised placebo-controlled study
-
Swedberg K, Komajda M, Böhm M, Borer JS, Ford I, Dubost-Brama A, et al. Ivabradine and outcomes in chronic heart failure (SHIFT): A randomised placebo-controlled study. Lancet. 2010;376(9744):875-85.
-
(2010)
Lancet
, vol.376
, Issue.9744
, pp. 875-885
-
-
Swedberg, K.1
Komajda, M.2
Böhm, M.3
Borer, J.S.4
Ford, I.5
Dubost-Brama, A.6
-
7
-
-
0029928495
-
Heart rate variability: Standards of measurement, physiological interpretation and clinical use
-
Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology
-
Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation. 1996;93(5):1043-65.
-
(1996)
Circulation
, vol.93
, Issue.5
, pp. 1043-1065
-
-
-
8
-
-
0030222178
-
Short and long-term reproducibility of time and frequency domain heart rate variability measurements in normal subjects
-
Pitzalis MV, Mastropasqua F, Massari F, Forleo C, Di Maggio M, Passantino A, et al. Short and long-term reproducibility of time and frequency domain heart rate variability measurements in normal subjects. Cardiovasc Res. 1996;32(2):226-33.
-
(1996)
Cardiovasc Res
, vol.32
, Issue.2
, pp. 226-233
-
-
Pitzalis, M.V.1
Mastropasqua, F.2
Massari, F.3
Forleo, C.4
Di Maggio, M.5
Passantino, A.6
-
9
-
-
0037211978
-
Prognostic significance of heart rate variability in dilated cardiomyopathy
-
Karcz M, Chojnowska L, Zareba W, Ruzyllo W. Prognostic significance of heart rate variability in dilated cardiomyopathy. Int J Cardiol. 2003;87(1):75-81.
-
(2003)
Int J Cardiol
, vol.87
, Issue.1
, pp. 75-81
-
-
Karcz, M.1
Chojnowska, L.2
Zareba, W.3
Ruzyllo, W.4
-
10
-
-
0030865310
-
Heart rate variability in idiopathic dilated cardiomyopathy: Characteristics and prognostic value
-
Fauchier L, Babuty D, Cosnay P, Autret ML, Fauchier JP. Heart rate variability in idiopathic dilated cardiomyopathy: characteristics and prognostic value. J Am Coll Cardiol. 1997;30(4):1009-14.
-
(1997)
J Am Coll Cardiol
, vol.30
, Issue.4
, pp. 1009-1014
-
-
Fauchier, L.1
Babuty, D.2
Cosnay, P.3
Autret, M.L.4
Fauchier, J.P.5
-
11
-
-
0030229169
-
Heart rate variability: Two eras of investigation
-
Binkley PF. Heart rate variability: two eras of investigation. J Card Fail. 1996;2(3):193-6.
-
(1996)
J Card Fail
, vol.2
, Issue.3
, pp. 193-196
-
-
Binkley, P.F.1
-
12
-
-
0036642639
-
Prognostic value of heart rate variability in chronic congestive heart failure (Veterans Affairs’ Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure)
-
Bilchick KC, Fetics B, Djoukeng R, Fisher SG, Fletcher RD, Singh SN, et al. Prognostic value of heart rate variability in chronic congestive heart failure (Veterans Affairs’ Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure). Am J Cardiol. 2002;90(1):24-8.
-
(2002)
Am J Cardiol
, vol.90
, Issue.1
, pp. 24-28
-
-
Bilchick, K.C.1
Fetics, B.2
Djoukeng, R.3
Fisher, S.G.4
Fletcher, R.D.5
Singh, S.N.6
-
13
-
-
84897413958
-
Sympathetic overactivity in hypertension and cardiovascular disease
-
Manolis AJ, Poulimenos LE, Kallistratos MS, Gavras I, Gavras H. Sympathetic overactivity in hypertension and cardiovascular disease. Curr Vasc Pharmacol. 2014;12(1):4-15.
-
(2014)
Curr Vasc Pharmacol
, vol.12
, Issue.1
, pp. 4-15
-
-
Manolis, A.J.1
Poulimenos, L.E.2
Kallistratos, M.S.3
Gavras, I.4
Gavras, H.5
-
14
-
-
84885304142
-
ASSOCIATE investigators. Effects of ivabradine in patients with stable angina receiving beta-blockers according to baseline heart rate: An analysis of the ASSOCIATE study
-
Tardif JC, Ponikowski P, Kahan T; ASSOCIATE investigators. Effects of ivabradine in patients with stable angina receiving beta-blockers according to baseline heart rate: an analysis of the ASSOCIATE study. Int J Cardiol. 2013;168(2):789-94.
-
(2013)
Int J Cardiol
, vol.168
, Issue.2
, pp. 789-794
-
-
Tardif, J.C.1
Ponikowski, P.2
Kahan, T.3
-
15
-
-
78650451971
-
American Society of Echocardiography recommendations for quality echocardiography laboratory operations
-
Picard MH, Adams D, Bierig SM, Dent JM, Douglas PS, Gillam LD, et al. American Society of Echocardiography recommendations for quality echocardiography laboratory operations. J Am Soc Echocardiogr. 2011;24(1):1-10.
-
(2011)
J Am Soc Echocardiogr
, vol.24
, Issue.1
, pp. 1-10
-
-
Picard, M.H.1
Adams, D.2
Bierig, S.M.3
Dent, J.M.4
Douglas, P.S.5
Gillam, L.D.6
-
16
-
-
4544344025
-
Heart rate lowering by specific and selective I(f) current inhibition with ivabradine: A new therapeutic perspective in cardiovascular disease
-
Di Francesco D, Camm AJ. Heart rate lowering by specific and selective I(f) current inhibition with ivabradine: a new therapeutic perspective in cardiovascular disease. Drugs. 2004;64(16):1757-65.
-
(2004)
Drugs
, vol.64
, Issue.16
, pp. 1757-1765
-
-
Di Francesco, D.1
Camm, A.J.2
-
17
-
-
33645513944
-
Properties of ivabradine induced block of HCN1 and HCN4 pacemaker channels
-
Bucchi A, Tognati A, Milanesi R, Baruscotti M, DiFrancesco D. Properties of ivabradine induced block of HCN1 and HCN4 pacemaker channels. J Physiol. 2006;572(Pt 2):335-46.
-
(2006)
J Physiol
, vol.572
, pp. 335-346
-
-
Bucchi, A.1
Tognati, A.2
Milanesi, R.3
Baruscotti, M.4
Difrancesco, D.5
-
18
-
-
70349669250
-
BEAUTIFUL Investigators. Relationship between ivabradine treatment and cardiovascular outcomes in patients with stable coronary artery disease and left ventricular systolic dysfunction with limiting angina: A subgroup analysis of the randomized, controlled BEAUTIFUL trial
-
Fox K, Ford I, Steg PG, Tendera M, Robertson M, Ferrari R; BEAUTIFUL Investigators. Relationship between ivabradine treatment and cardiovascular outcomes in patients with stable coronary artery disease and left ventricular systolic dysfunction with limiting angina: a subgroup analysis of the randomized, controlled BEAUTIFUL trial. Eur Heart J. 2009;30(19):2337-45.
-
(2009)
Eur Heart J
, vol.30
, Issue.19
, pp. 2337-2345
-
-
Fox, K.1
Ford, I.2
Steg, P.G.3
Tendera, M.4
Robertson, M.5
Ferrari, R.6
-
19
-
-
78651275247
-
Impact of ‘’off-label’’ use of ivabradine on exercise capacity, gas exchange, functional class, quality of life, and neurohormonal modulation in patients with ischemic chronic heart failure
-
Sarullo FM, Fazio G, Puccio D, Fasullo S, Paterna S, Novo S, et al. Impact of ‘’off-label’’ use of ivabradine on exercise capacity, gas exchange, functional class, quality of life, and neurohormonal modulation in patients with ischemic chronic heart failure. J Cardiovasc Pharmacol Ther. 2010;15(4):349-55.
-
(2010)
J Cardiovasc Pharmacol Ther
, vol.15
, Issue.4
, pp. 349-355
-
-
Sarullo, F.M.1
Fazio, G.2
Puccio, D.3
Fasullo, S.4
Paterna, S.5
Novo, S.6
-
20
-
-
80052322413
-
Effect of Carvedilol, Ivabradine or their combination on exercise capacity in patients with Heart Failure (the CARVIVA HF trial)
-
Volterrani M, Cice G, Caminiti G, Vitale C, D’Isa S, Perrone Filardi P, et al. Effect of Carvedilol, Ivabradine or their combination on exercise capacity in patients with Heart Failure (the CARVIVA HF trial). Int J Cardiol. 2011;151(2):218-24.
-
(2011)
Int J Cardiol
, vol.151
, Issue.2
, pp. 218-224
-
-
Volterrani, M.1
Cice, G.2
Caminiti, G.3
Vitale, C.4
D’isa, S.5
Perrone Filardi, P.6
-
21
-
-
70450224100
-
Comparison of ivabradine versus metoprolol in early phases of reperfused anterior myocardial infarction with impaired left ventricular function: Preliminary findings
-
Fasullo S, Cannizzaro S, Maringhini G, Ganci F, Giambanco F, Vitale G, et al. Comparison of ivabradine versus metoprolol in early phases of reperfused anterior myocardial infarction with impaired left ventricular function: preliminary findings. J Card Fail. 2009;15(10):856-63.
-
(2009)
J Card Fail
, vol.15
, Issue.10
, pp. 856-863
-
-
Fasullo, S.1
Cannizzaro, S.2
Maringhini, G.3
Ganci, F.4
Giambanco, F.5
Vitale, G.6
-
22
-
-
0027955938
-
Reduced heart rate variability and mortality risk in an elderly cohort. The Framingham Heart Study
-
Tsuji H, Venditti FJ Jr, Manders ES, Evans JC, Larson MG, Feldman CL, et al. Reduced heart rate variability and mortality risk in an elderly cohort. The Framingham Heart Study. Circulation. 1994;90(2):878-83.
-
(1994)
Circulation
, vol.90
, Issue.2
, pp. 878-883
-
-
Tsuji, H.1
Venditti, F.J.2
Manders, E.S.3
Evans, J.C.4
Larson, M.G.5
Feldman, C.L.6
-
23
-
-
77955444570
-
Differences in autonomic activity in individuals with optimal, normal, and high-normal blood pressure levels
-
Doğru MT, Simşek V, Sahin O, Ozer N. Differences in autonomic activity in individuals with optimal, normal, and high-normal blood pressure levels. Turk Kardiyol Dern Ars. 2010;38(3):182-8.
-
(2010)
Turk Kardiyol Dern Ars
, vol.38
, Issue.3
, pp. 182-188
-
-
Doğru, M.T.1
Simşek, V.2
Sahin, O.3
Ozer, N.4
-
24
-
-
84877108264
-
Heart rate variability and heart rate recovery in patients with type 1 diabetes mellitus
-
Turker Y, Aslantas Y, Aydin Y, Demirin H, Kutlucan A, Tibilli H, et al. Heart rate variability and heart rate recovery in patients with type 1 diabetes mellitus. Acta Cardiol. 2013;68(2):145-50.
-
(2013)
Acta Cardiol
, vol.68
, Issue.2
, pp. 145-150
-
-
Turker, Y.1
Aslantas, Y.2
Aydin, Y.3
Demirin, H.4
Kutlucan, A.5
Tibilli, H.6
-
25
-
-
84881141413
-
Relation of short term heart rate variability to incident heart failure (from the Multi Ethnic Study of Atherosclerosis)
-
Shah SA, Kambur T, Chan C, Herrington DM, Liu K, Shah SJ. Relation of short‑term heart rate variability to incident heart failure (from the Multi‑Ethnic Study of Atherosclerosis). Am J Cardiol. 2013;112(4):533-40.
-
(2013)
Am J Cardiol
, vol.112
, Issue.4
, pp. 533-540
-
-
Shah, S.A.1
Kambur, T.2
Chan, C.3
Herrington, D.M.4
Liu, K.5
Shah, S.J.6
-
26
-
-
84872264274
-
Prognostic role of heart rate variability in patients with ST-segment elevation acute myocardial infarction treated by primary angioplasty
-
Coviello I, Pinnacchio G, Laurito M, Stazi A, Battipaglia I, Barone L, et al. Prognostic role of heart rate variability in patients with ST-segment elevation acute myocardial infarction treated by primary angioplasty. Cardiology. 2013;124(1):63-70.
-
(2013)
Cardiology
, vol.124
, Issue.1
, pp. 63-70
-
-
Coviello, I.1
Pinnacchio, G.2
Laurito, M.3
Stazi, A.4
Battipaglia, I.5
Barone, L.6
-
27
-
-
69949088284
-
Heart rate variability increases with reductions in cigarette smoke exposure after 3 days
-
Munjal S, Koval T, Muhammad R, Jin Y, Demmel V, Roethig HJ, et al. Heart rate variability increases with reductions in cigarette smoke exposure after 3 days. J Cardiovasc Pharmacol Ther. 2009;14(3):192-8.
-
(2009)
J Cardiovasc Pharmacol Ther
, vol.14
, Issue.3
, pp. 192-198
-
-
Munjal, S.1
Koval, T.2
Muhammad, R.3
Jin, Y.4
Demmel, V.5
Roethig, H.J.6
-
28
-
-
0842281506
-
Influence of age, gender, body mass index, and functional capacity on heart rate variability in a cohort of subjects without heart disease
-
Antelmi I, de Paula RS, Shinzato AR, Peres CA, Mansur AJ, Grupi CJ. Influence of age, gender, body mass index, and functional capacity on heart rate variability in a cohort of subjects without heart disease. Am J Cardiol. 2004;93(3):381-5.
-
(2004)
Am J Cardiol
, vol.93
, Issue.3
, pp. 381-385
-
-
Antelmi, I.1
De Paula, R.S.2
Shinzato, A.R.3
Peres, C.A.4
Mansur, A.J.5
Grupi, C.J.6
-
29
-
-
84887767930
-
Impaired heart rate variability in patients with mitral annular calcification: An observational study
-
Kurtoglu E, Akturk E, Korkmaz H, Atas H, Cuglan B, Pekdemir H. Impaired heart rate variability in patients with mitral annular calcification: an observational study. Anadolu Kardiyol Derg. 2013;13(7):668-74.
-
(2013)
Anadolu Kardiyol Derg
, vol.13
, Issue.7
, pp. 668-674
-
-
Kurtoglu, E.1
Akturk, E.2
Korkmaz, H.3
Atas, H.4
Cuglan, B.5
Pekdemir, H.6
-
30
-
-
0034991027
-
Effect of beta-blockade on heart rate variability in decompensated heart failure
-
Aronson D, Burger AJ. Effect of beta-blockade on heart rate variability in decompensated heart failure. Int J Cardiol. 2001;79(1):31-9.
-
(2001)
Int J Cardiol
, vol.79
, Issue.1
, pp. 31-39
-
-
Aronson, D.1
Burger, A.J.2
-
31
-
-
29144455179
-
Changes in heart rate variability are correlated to hemodynamic improvement with chronic CARVEDILOL therapy in heart failure
-
Bullinga JR, Alharethi R, Schram MS, Bristow MR, Gilbert EM. Changes in heart rate variability are correlated to hemodynamic improvement with chronic CARVEDILOL therapy in heart failure. J Card Fail. 2005;11(9):693-9.
-
(2005)
J Card Fail
, vol.11
, Issue.9
, pp. 693-699
-
-
Bullinga, J.R.1
Alharethi, R.2
Schram, M.S.3
Bristow, M.R.4
Gilbert, E.M.5
-
32
-
-
0033059974
-
The effects of metoprolol and captopril on heart rate variability in patients with idiopathic dilated cardiomyopathy
-
Jansson K, Hagerman I, Ostlund R, Karlberg KE, Nylander E, Nyquist O, et al. The effects of metoprolol and captopril on heart rate variability in patients with idiopathic dilated cardiomyopathy. Clin Cardiol. 1999;22(6):397-402.
-
(1999)
Clin Cardiol
, vol.22
, Issue.6
, pp. 397-402
-
-
Jansson, K.1
Hagerman, I.2
Ostlund, R.3
Karlberg, K.E.4
Nylander, E.5
Nyquist, O.6
-
33
-
-
2542523785
-
Beneficial effect of candesartan treatment on cardiac autonomic nervous activity in patients with chronic heart failure: Simultaneous recording of ambulatory electrocardiogram and posture
-
Tambara K, Fujita M, Sumita Y, Miyamoto S, Sekiguchi H, Eiho S, et al. Beneficial effect of candesartan treatment on cardiac autonomic nervous activity in patients with chronic heart failure: simultaneous recording of ambulatory electrocardiogram and posture. Clin Cardiol. 2004;27(5):300-3.
-
(2004)
Clin Cardiol
, vol.27
, Issue.5
, pp. 300-303
-
-
Tambara, K.1
Fujita, M.2
Sumita, Y.3
Miyamoto, S.4
Sekiguchi, H.5
Eiho, S.6
-
34
-
-
1542496392
-
Comparison of the effect of valsartan and lisinopril on autonomic nervous system activity in chronic heart failure
-
De Tommasi E, Iacoviello M, Romito R, Ceconi C, Guida P, Massari F, et al. Comparison of the effect of valsartan and lisinopril on autonomic nervous system activity in chronic heart failure. Am Heart J. 2003;146(5):E17.
-
(2003)
Am Heart J
, vol.146
, Issue.5
, pp. E17
-
-
De Tommasi, E.1
Iacoviello, M.2
Romito, R.3
Ceconi, C.4
Guida, P.5
Massari, F.6
-
35
-
-
0035370038
-
Circadian variation in the effects of aldosterone blockade on heart rate variability and QT dispersion in congestive heart failure
-
Yee KM, Pringle SD, Struthers AD. Circadian variation in the effects of aldosterone blockade on heart rate variability and QT dispersion in congestive heart failure. J Am Coll Cardiol. 2001;37(7):1800-7.
-
(2001)
J Am Coll Cardiol
, vol.37
, Issue.7
, pp. 1800-1807
-
-
Yee, K.M.1
Pringle, S.D.2
Struthers, A.D.3
-
36
-
-
33646750506
-
Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction
-
Gislason GH, Rasmussen V, Abildstrom SZ, Gadsboll N, Buch P, Friberg J, et al. Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction. Eur Heart J. 2006;27(10):1153-8.
-
(2006)
Eur Heart J
, vol.27
, Issue.10
, pp. 1153-1158
-
-
Gislason, G.H.1
Rasmussen, V.2
Abildstrom, S.Z.3
Gadsboll, N.4
Buch, P.5
Friberg, J.6
-
37
-
-
72449138051
-
Challenging the dogma of high target doses in the treatment of heart failure: Is more always better?
-
Follath F. Challenging the dogma of high target doses in the treatment of heart failure: is more always better? Arch Cardiovasc Dis. 2009;102(11):785-9.
-
(2009)
Arch Cardiovasc Dis
, vol.102
, Issue.11
, pp. 785-789
-
-
Follath, F.1
-
38
-
-
78650921528
-
Heart rate reduction by ivabradine reduces diastolic dysfunction and cardiac fibrosis
-
Busseuil D, Shi Y, Mecteau M, Brand G, Gillis MA, Thorin E, et al. Heart rate reduction by ivabradine reduces diastolic dysfunction and cardiac fibrosis. Cardiology. 2010;117(3):234-42.
-
(2010)
Cardiology
, vol.117
, Issue.3
, pp. 234-242
-
-
Busseuil, D.1
Shi, Y.2
Mecteau, M.3
Brand, G.4
Gillis, M.A.5
Thorin, E.6
-
39
-
-
80054742115
-
SHIFT Investigators. Effects of selective heart rate reduction with ivabradine on left ventricular remodelling and function: Results from the SHIFT echocardiography substudy
-
Tardif JC, O’Meara E, Komajda M, Böhm M, Borer JS, Ford I, et al; SHIFT Investigators. Effects of selective heart rate reduction with ivabradine on left ventricular remodelling and function: results from the SHIFT echocardiography substudy. Eur Heart J. 2011;32(20):2507-15.
-
(2011)
Eur Heart J
, vol.32
, Issue.20
, pp. 2507-2515
-
-
Tardif, J.C.1
O’meara, E.2
Komajda, M.3
Böhm, M.4
Borer, J.S.5
Ford, I.6
-
40
-
-
44949127974
-
Chronic heart rate reduction by ivabradine prevents endothelial dysfunction in dyslipidaemic mice
-
Drouin A, Gendron ME, Thorin E, Gillis MA, Mahlberg-Gaudin F, Tardif JC. Chronic heart rate reduction by ivabradine prevents endothelial dysfunction in dyslipidaemic mice. Br J Pharmacol. 2008;154(4):749-57.
-
(2008)
Br J Pharmacol
, vol.154
, Issue.4
, pp. 749-757
-
-
Drouin, A.1
Gendron, M.E.2
Thorin, E.3
Gillis, M.A.4
Mahlberg-Gaudin, F.5
Tardif, J.C.6
|